Status:
COMPLETED
Development of a Digital Tool for the Individualization of Speech Therapy Care for Premature Newborns
Lead Sponsor:
Centre Hospitalier Sud Francilien
Conditions:
Premature Birth
Eligibility:
All Genders
24-3 years
Phase:
NA
Brief Summary
The study concerns the creation and implementation of a digital tool presenting the various orofacial stimuli that can be offered to premature newborns. This app is intended for parents, to allow them...
Detailed Description
Two groups will be formed: Group A - control: receiving the speech therapy currently in place in the department. Group B - experimental: will receive the same care as the first group, plus access to...
Eligibility Criteria
Inclusion
- Child born prematurely before 29 weeks of amenorrhea (SA).
- Alive for minimum 24h.
- Holders of parental authority who have been informed of the study and have not objected.
Exclusion
- Child born after 29 weeks of amenorrhea.
- with a genetic or severe neurological pathology or withdrawal syndrome.
- with a vital prognosis.
- whose family home is too far from the service.
Key Trial Info
Start Date :
September 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 20 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05992181
Start Date
September 15 2023
End Date
June 20 2024
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, 91106